NCT07470606 2026-03-13
MemoryRT
The University of Texas Health Science Center at San Antonio
Phase 2 Not yet recruiting
Clinical Trials
17 trialsNCT06055179 2025-07-01
XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)
Guangzhou University of Traditional Chinese Medicine
Phase NA Recruiting
NCT00427700 2024-08-21
Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome
Hospital de Clinicas de Porto Alegre
Phase 3 Completed
NCT04926545 2024-07-30
XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)
Guangzhou University of Traditional Chinese Medicine
Phase NA Completed
NCT01077817 2022-02-03
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
Organon and Co
Completed
NCT00710970 2022-01-24
Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment
Baylor College of Medicine
Phase 2 Completed
NCT03147196 2019-01-22
Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Mayo Clinic
Phase 2 Withdrawn
NCT00723398 2018-11-01
Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention
Milton S. Hershey Medical Center
Phase NA Completed
NCT01607320 2018-09-20
PCOS
Prisma Health-Upstate
Phase NA Terminated
NCT00687102 2018-09-12
Co-STAR
Wake Forest University Health Sciences
Phase 3 Completed
NCT01050842 2017-03-23
Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT00003906 2015-10-06
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
NSABP Foundation Inc
Phase 3 Completed
NCT00031850 2013-06-26
Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer
National Cancer Institute (NCI)
Phase NA Completed
NCT00019500 2013-06-20
Raloxifene in Preventing Breast Cancer in Premenopausal Women
National Cancer Institute (NCI)
Phase 2 Completed
NCT00004915 2012-06-06
Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer
Northwestern University
Phase 2 Completed
NCT00031811 2012-05-28
Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer
OHSU Knight Cancer Institute
Phase NA Completed
NCT00190593 2007-01-26
Raloxifene Use for The Heart
Eli Lilly and Company
Phase 3 Completed